LUBRICANT, SURGICAL

The contract is for the procurement of surgical lubricant, a sterile, latex-free, water-soluble jelly containing parabens, with each packet holding 2.7 grams and each box containing 144 packets, unit of issue being a box. The item is regulated by the FDA and must meet the DLA Master List of Technical and Quality Requirements, which supersede all other standards including ASTM D3951 and MIL-STD-129. Medical packaging and labeling must comply with Medical Marking Standard No. 1, which replaces MIL-STD-129 for medical items, requiring durable, legible markings including NSN, lot number, expiration date, unit of issue, and quantity per unit pack using GS1-128 or Data Matrix barcodes. The lubricant has a non-extendable 36-month shelf life and must be stored between 20°C and 25°C (68°F to 77°F). Packaging must be commercial grade with sealed unit containers and exterior shipping containers suitable for safe transport by common carrier at the lowest cost; palletization follows DLA’s RP001 requirements. Hazardous material provisions under FED-STD-313 trigger IP025 packaging, otherwise ASTM D3951 applies, but DLA standards take precedence. Delivery is FOB destination within 20 days of order receipt, with exact quantity requirements and no variance allowed. Shipments must be sent via traceable freight, prohibiting parcel post, and delivered to Joint Base Charleston, SC. Four CLINs are listed with identical items and delivery dates of either May 15 or May 18, 2026, but no unit or total prices are specified. Contractors must comply with FAR and DFARS clauses including equal opportunity, trafficking in persons, employment eligibility, sustainable products, cybersecurity safeguards, hazardous material safety, export control, and prohibition on certain Chinese military company products. Electronic payment submission via WAWF is mandatory, and all offerors must have an active UEI and CAGE code. Representations regarding small business status, socioeconomic categories, and compliance with covered defense telecommunications restrictions are required. All technical, quality, packaging, and labeling requirements are governed by the DLA Master List, with medical-specific marking under MMS No. 1, and no deviations from specified standards are permitted.